Zhu Xiaofan: Clinical Trials

1 trial sponsored by Zhu Xiaofan, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 recruiting. 1 Not applicable.

By phase and status

PhaseTrialsStatus
Not applicable1Recruiting 1

Follow Zhu Xiaofan: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
CD19-targeted CAR T Cell Autotransfusion for the Treatment of Recurrent/Refractory B-cell Acute Lymphoblastic Leukemia/Lymphoblastic Lymphoma in Children With CD19+
CAR T cell injection - B Lymphocytic Leukemia, B Lymphoblastic Lymphoma
Not applicableRecruitingZhu Xiaofan602024-02-012024-04-09

Conditions studied

Leukemia, B-Cell (1)  ·  Precursor B-Cell Lymphoblastic Leukemia-Lymphoma (1)

Interventions

Immunotherapy, Adoptive (1)

Countries

China (1)